Cite

HARVARD Citation

    de Vries-Brilland, M. et al. (2020). Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study. European journal of cancer. pp. 76-83. [Online]. 
  
Back to record